tiprankstipranks
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market
2696
Shanghai Henlius Biotech, Inc. Class H
RESEARCH TOOLSreports

Shanghai Henlius Biotech, Inc. Class H (2696) Ratios

7 Followers

Shanghai Henlius Biotech, Inc. Class H Ratios

HK:2696's free cash flow for Q2 2025 was ¥0.78. For the 2025 fiscal year, HK:2696's free cash flow was decreased by ¥ and operating cash flow was ¥0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.68 0.50 0.53 0.44 0.56
Quick Ratio
 0.50 0.35 0.38 0.29 0.41
Cash Ratio
 0.19 0.15 0.19 0.13 0.05
Solvency Ratio
 0.10 0.15 0.11 -0.06 -0.16
Operating Cash Flow Ratio
 0.10 0.25 0.21 0.20 0.03
Short-Term Operating Cash Flow Coverage
 0.19 0.50 0.39 0.40 0.06
Net Current Asset Value
¥ -4.92B¥ -5.07B¥ -5.04B¥ -5.10B¥ -3.23B
Leverage Ratios
Debt-to-Assets Ratio
 0.32 0.34 0.41 0.41 0.37
Debt-to-Equity Ratio
 1.08 1.21 1.87 2.25 1.14
Debt-to-Capital Ratio
 0.52 0.55 0.65 0.69 0.53
Long-Term Debt-to-Capital Ratio
 0.21 0.24 0.34 0.37 0.27
Financial Leverage Ratio
 3.39 3.52 4.52 5.45 3.12
Debt Service Coverage Ratio
 0.32 0.43 0.31 -0.12 -0.44
Interest Coverage Ratio
 9.24 7.64 5.71 -5.95 -7.84
Debt to Market Cap
 0.09 0.28 0.53 0.56 0.24
Interest Debt Per Share
 6.88 6.94 7.70 6.98 5.04
Net Debt to EBITDA
 3.25 2.51 3.41 -9.67 -3.67
Profitability Margins
Gross Profit Margin
76.33%73.10%72.64%73.73%68.93%
EBIT Margin
14.84%15.14%11.71%-18.30%-51.82%
EBITDA Margin
19.89%20.02%16.89%-9.66%-39.93%
Operating Profit Margin
14.84%16.41%11.71%-19.55%-39.54%
Pretax Profit Margin
14.36%14.78%10.56%-21.58%-56.87%
Net Profit Margin
14.09%14.33%10.12%-21.63%-58.49%
Continuous Operations Profit Margin
14.09%14.33%10.12%-21.63%-58.49%
Net Income Per EBT
98.12%97.00%95.86%100.20%102.85%
EBT Per EBIT
96.80%90.07%90.17%110.40%143.82%
Return on Assets (ROA)
5.26%7.74%5.51%-7.79%-13.72%
Return on Equity (ROE)
18.53%27.23%24.91%-42.49%-42.85%
Return on Capital Employed (ROCE)
9.37%16.87%13.06%-16.02%-15.79%
Return on Invested Capital (ROIC)
6.67%11.21%7.93%-9.75%-11.50%
Return on Tangible Assets
10.32%15.65%8.22%-15.14%-27.81%
Earnings Yield
1.60%6.78%7.54%-11.35%-10.19%
Efficiency Ratios
Receivables Turnover
 3.62 6.35 7.39 7.06 5.69
Payables Turnover
 1.32 2.11 2.71 1.18 1.36
Inventory Turnover
 1.22 2.11 1.95 1.12 1.24
Fixed Asset Turnover
 1.64 2.12 2.03 1.44 1.01
Asset Turnover
 0.37 0.54 0.54 0.36 0.23
Working Capital Turnover Ratio
 -2.87 -2.33 -2.07 -1.56 -2.43
Cash Conversion Cycle
 123.81 57.27 101.96 70.63 89.74
Days of Sales Outstanding
 100.87 57.47 49.41 51.72 64.16
Days of Inventory Outstanding
 299.91 172.63 187.27 327.27 293.34
Days of Payables Outstanding
 276.97 172.83 134.72 308.36 267.75
Operating Cycle
 400.78 230.10 236.68 378.99 357.49
Cash Flow Ratios
Operating Cash Flow Per Share
 0.91 2.29 1.92 1.81 0.17
Free Cash Flow Per Share
 0.86 0.74 0.07 -0.71 -1.94
CapEx Per Share
 0.06 1.54 1.85 2.52 2.10
Free Cash Flow to Operating Cash Flow
 0.94 0.33 0.03 -0.39 -11.51
Dividend Paid and CapEx Coverage Ratio
 16.42 1.48 1.04 0.72 0.08
Capital Expenditure Coverage Ratio
 16.42 1.48 1.04 0.72 0.08
Operating Cash Flow Coverage Ratio
 0.13 0.34 0.26 0.27 0.03
Operating Cash Flow to Sales Ratio
 0.11 0.22 0.19 0.31 0.05
Free Cash Flow Yield
1.23%3.35%0.50%-6.26%-10.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 62.43 14.74 13.27 -8.81 -9.81
Price-to-Sales (P/S) Ratio
 8.80 2.11 1.34 1.91 5.74
Price-to-Book (P/B) Ratio
 11.12 4.01 3.30 3.74 4.20
Price-to-Free Cash Flow (P/FCF) Ratio
 81.50 29.89 198.57 -15.97 -9.28
Price-to-Operating Cash Flow Ratio
 76.54 9.74 6.91 6.24 106.83
Price-to-Earnings Growth (PEG) Ratio
 0.62 0.30 -0.07 0.29 3.69
Price-to-Fair Value
 11.12 4.01 3.30 3.74 4.20
Enterprise Value Multiple
 47.49 13.06 11.36 -29.39 -18.05
Enterprise Value
 40.69B 14.97B 10.35B 9.13B 12.12B
EV to EBITDA
 47.49 13.06 11.36 -29.39 -18.05
EV to Sales
 9.44 2.62 1.92 2.84 7.21
EV to Free Cash Flow
 87.48 37.00 283.70 -23.80 -11.65
EV to Operating Cash Flow
 82.15 12.06 9.88 9.30 134.13
Tangible Book Value Per Share
 -4.16 -4.31 -1.96 -4.97 -2.49
Shareholders’ Equity Per Share
 6.27 5.54 4.02 3.02 4.27
Tax and Other Ratios
Effective Tax Rate
 0.02 0.03 0.04 >-0.01 -0.03
Revenue Per Share
 7.93 10.53 9.88 5.93 3.13
Net Income Per Share
 1.12 1.51 1.00 -1.28 -1.83
Tax Burden
 0.98 0.97 0.96 1.00 1.03
Interest Burden
 0.97 0.98 0.90 1.18 1.10
Research & Development to Revenue
 0.20 0.18 0.21 0.43 0.61
SG&A to Revenue
 0.41 0.40 0.07 0.11 0.17
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 0.03
Income Quality
 0.82 1.51 1.84 -1.41 -0.09
Currency in CNY